Testosterone replacement therapy (TRT) for male hypogonadism is rapidly gaining popularity and acceptance. Options include gels, injections, and implantable subcutaneous pellets.The aim of this study was to determine rates of patient satisfaction and reasons for patient preferences in hypogonadal men on TRT.An anonymous, prospective survey was distributed to men presenting for TRT at an academic urology clinic. The survey was organized into multiple domains including patient satisfaction and treatment motivation.Patient satisfaction responses obtained via anonymous survey.Average patient age was 49 ± 0.7 years (n = 382). Injectable testosterone was chosen by 53
作者:Jason R, Kovac;Saneal, Rajanahally;Ryan P, Smith;Robert M, Coward;Dolores J, Lamb;Larry I, Lipshultz
来源:The journal of sexual medicine 2014 年 11卷 2期